Features | Partner Sites | Information | LinkXpress
Sign In
ElsMed
Schiller
Ampronix

Hepatic Function SPECT Testing Before and During Radiotherapy Can Help in Treatment Planning for Liver Cancer Patients

By Medimaging International staff writers
Posted on 26 Feb 2013
Monitoring the hepatic function of unresectable liver cancer patients evaluated by 99mTc-labeled iminodiacetic acid (HIDA) used with single-photon emission computed tomography (SPECT) imaging before and during radiation therapy provides critical data that could guide more customized treatment plans and reduce risks of liver injury, according to recent research.

The study’s findings were presented at the 2013 Cancer Imaging and Radiation Therapy Symposium, held February 8–9, 2013, in Orlando (FL, USA). This Symposium is sponsored by the American Society for Radiation Oncology (ASTRO; Fairfax, VA, USA) and the Radiological Society of North American (RSNA; Oak Brook, IL, USA). This research included 14 patients who had unresectable intrahepatic tumors and were treated with three-dimensional conformal radiation therapy (3D CRT), intensity-modulated radiation therapy (IMRT) or stereotactic body radiation therapy (SBRT) at a median dose of 52 Gy. Patients underwent HIDA SPECT scanning prior to radiation therapy, after delivery of 50%–60% of the planned doses and one month after completion of radiation therapy. Moreover, indocyanine green tests, a measure of overall liver function, were performed +/- one day of each SPECT scan. The 27 dynamic HIDA SPECT volumes were captured over a 60-minute period after the administration of 10 mCi 99mTc-labeled HIDA on a SPECT/CT scanner.

Gauging the regional liver function prior to radiation therapy allows assessment of the precondition of the patient’s liver function. Assessing the change of the regional liver function during the mid-course of radiation therapy indicates the response of the individual patient’s liver to radiation doses. Integrating the planned radiation doses with the regional liver function evaluation and reassessment, the researchers devised a model to predict the regional liver function postradiation therapy. This information is key to providing patients with the optimal radiation doses for better tumor control, while minimizing the risk for each patient.

“Through this assessment method, patients could potentially receive more treatment doses tailored to meet their needs, based on their liver function,” said Hesheng Wang, PhD, the lead study author and a postdoctoral fellow in radiation oncology at the University of Michigan in (Ann Arbor, MI, USA). “The physiological adaptation of radiation therapy based upon individual response assessment is a valuable new paradigm worth additional testing.”

Related Links:

University of Michigan



Channels

Radiography

view channel
Image: Whole body images of a mouse before and after nanoparticles injections. Signal loss in the liver and the spleen due to the accumulation of iron from the nanoparticles is indicated by the red arrows. (Photo courtesy of Imperial College London).

Self-Assembling Nanoparticles Could Improve Cancer Diagnosis

Innovative nanoparticles boost the effectiveness of magnetic resonance imaging (MRI) scanning by specifically seeking out receptors that are found in cancerous cells. Developed by researchers at Imperial... Read more

MRI

view channel
Image: Probability map of the brain regions activated in functional magnetic resonance imaging (fMRI) by a silent sentence production task in a group of 144 right-handed individuals. The color scale indicates the percentage of subjects with significant activation in this area during the task (green: 50%, blue: 65%, red: 80% or more). Note the high asymmetry of the map in favor of the left hemisphere) [Gauche = Left, Droite = Right] (Photo courtresy of Groupe d\'Imagerie Neurofonctionnelle, CNRS/CEA/Université de Bordeaux, France).

fMRI and Database Show a Dominant Side of the Brain for Handedness and Language

Utilizing a large psychometric and brain imaging database, researchers have demonstrated that the location of language areas in the brain is independent of left- or right-handedness, except for a very... Read more

Ultrasound

view channel
Image: The Vivid T8 cardiovascular ultrasound system offers quantitative features such as stress echo and transesophageal echocardiography (TEE) capabilities (Photo courtesy of GE Healthcare).

Mobile, Cardiovascular Ultrasound Features Stress Echo and Transesophageal Echocardiography Capabilities

A 58.5-kg mobile cardiovascular ultrasound system features innovative quantitative features such as stress echo, and transesophageal echocardiography (TEE) capabilities, designed for healthcare providers... Read more

General/Advanced Imaging

view channel
Image: Participant fitted with fNIRS headgear (Photo courtesy of University of Pittsburgh Schools of the Health Sciences).

Portable Optical Imaging Tool Designed for Concussion Evaluation

Researchers have demonstrated that a portable, low-cost optical imaging application is useful in evaluation of concussions. Two separate research projects, published recently, represent important steps... Read more

Imaging IT

view channel

Enterprise Imaging and Content Management Technology Collaboration Designed to Optimize the Electronic Health Record

A joint solution developed for the US market provides multi-media, electronic content management for electronic health records (EHRs). The system provides real-time access to a patient’s full medical history across the hospital enterprise, enhancing decision-making and healthcare while lowering costs. The integration... Read more

Industry News

view channel

Hosting and Distribution Collaboration Established to Provide Radiation Dose Monitoring

PHS Technologies Group, LLC (Scottsdale, AZ, USA), a unit of PACSHealth, LLC, and a developer of software that monitors patient exposure to ionizing radiation, reported that Dell Healthcare and Life Sciences (Round Rock, TX, USA) will become a marketing, distribution, and hosting partner for its DoseMonitor OnLine software.... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.